• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].

作者信息

Baggi Alice, Quaglino Pietro, Rubatto Marco, Depenni Roberta, Guida Michele, Ascierto Paolo Antonio, Trojaniello Claudia, Queirolo Paola, Saponara Maristella, Peris Ketty, Spagnolo Francesco, Bianchi Luca, De Galitiis Federica, Potenza Maria Concetta, Proietti Ilaria, Marconcini Riccardo, Botticelli Andrea, Barbieri Vito, Licitra Lisa, Alfieri Salvatore, Ficorella Corrado, Cortellini Alessio, Fargnoli Maria Concetta, Troiani Teresa, Tondulli Luca, Zamparini Manuel, Bossi Paolo

机构信息

University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, Italy.

University of Turin, Dermatologic Clinic, Department of Medical Sciences Torino, Piemonte, Italy.

出版信息

Eur J Cancer. 2022 May;166:309-310. doi: 10.1016/j.ejca.2022.02.027. Epub 2022 Mar 24.

DOI:10.1016/j.ejca.2022.02.027
PMID:35341663
Abstract
摘要

相似文献

1
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].《西米普利单抗治疗局部晚期和转移性皮肤鳞状细胞癌的真实世界数据》的勘误 [《欧洲癌症杂志》157卷（2021年）250 - 258页]
Eur J Cancer. 2022 May;166:309-310. doi: 10.1016/j.ejca.2022.02.027. Epub 2022 Mar 24.
2
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.西妥昔单抗在局部晚期和转移性皮肤鳞状细胞癌中的真实世界数据。
Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15.
3
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.西妥昔单抗治疗局部晚期皮肤鳞状细胞癌：一项开放标签、2 期、单臂试验的结果。
Lancet Oncol. 2020 Feb;21(2):294-305. doi: 10.1016/S1470-2045(19)30728-4. Epub 2020 Jan 14.
4
[Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab].[西米普利单抗治疗局部晚期和转移性皮肤鳞状细胞癌]
Rev Med Liege. 2019 Jul;74(7-8):436-440.
5
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.西普单抗-rwlc 生存和流行病学研究在晚期皮肤鳞状细胞癌。
Future Oncol. 2020 Feb;16(4):11-19. doi: 10.2217/fon-2019-0762. Epub 2020 Jan 17.
6
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.西米普利单抗治疗局部晚期和转移性皮肤鳞状细胞癌：来自法国CAREPI研究组的真实世界经验。
Cancers (Basel). 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547.
7
Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report.接受西普单抗治疗局部晚期皮肤鳞状细胞癌后出现口腔溃疡和淋巴结类肉瘤样反应：一例报告。
Einstein (Sao Paulo). 2022 Mar 7;20:eRC6367. doi: 10.31744/einstein_journal/2022RC6367. eCollection 2022.
8
Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel.西妥昔单抗治疗局部晚期皮肤鳞状细胞癌：安全性、疗效和治疗方案中的地位。
Expert Rev Anticancer Ther. 2021 Apr;21(4):355-363. doi: 10.1080/14737140.2021.1876567. Epub 2021 Feb 7.
9
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab.在转移性皮肤鳞状细胞癌对西米普利单抗程序性细胞死亡蛋白1阻断完全缓解期间，同时发生高分期皮肤鳞状细胞癌。
JAAD Case Rep. 2021 Oct 20;18:23-25. doi: 10.1016/j.jdcr.2021.10.009. eCollection 2021 Dec.
10
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.确定使用西米普利单抗进行免疫治疗以治疗晚期皮肤鳞状细胞癌的候选者：专家意见
Ther Adv Med Oncol. 2022 Jan 9;14:17588359211066272. doi: 10.1177/17588359211066272. eCollection 2022.